# Protalix BioTherapeutics, Inc.: Form 8-K, filed Nov 12, 2013

- Company: [Protalix BioTherapeutics, Inc.](/companies/plx.md) (CIK 1006281)
- Form: 8-K
- Filed: 2013-11-12
- Accepted by EDGAR: Nov 12, 2013, 06:10 ET
- Period: 2013-11-07
- Accession: 0001144204-13-060136
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1006281/000114420413060136/v360064_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1006281/000114420413060136/

## Items reported

- Item 5.07: Shareholder vote results

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1006281/000114420413060136/v360064_8k.htm

Filed Nov 12, 2013.
Source: SEC EDGAR, the filing index for accession 0001144204-13-060136. Last ingested by Listed: Nov 10, 2026, 16:48 ET. No prices; not investment advice.
